Thursday, February 26, 2015 8:36:24 AM
I agree, KBLB's methodology will almost definately produce cheaper fibers which will definately help the company succeed over any E.coli competitors. I am unsure if he would be able to break that down into proteins and reprocess them any cheaper than the E.coli, though. That really shouldn't matter much in the short term, though.
We are also already working with WM and possibly others who are already testing our fibers. Spiber will not send out samples of fibers to test until 2017. That gives KBLB a ~3 year lead on them which hopefully Kim will take advantage of going forward.
The advantage of KBLB's method over Spiber's is that KBLB can scale up practically anywhere without the need for millions of dollars of equipment, specialized factories, and highly skilled workers. The disadvantage is that any changes that need to be made to customize the properties of the silk to meet the application cannot be done very quickly whereas Spiber can do it. This also causes longer initial production time for achieving consistency of the desired properties.
Yes, it looks like that was also part of it. The shares that were sold were not part of the grant that they got, but were sold to third parties, specifically Tohoku Innovation Capital Corporation, Shonai Bank, Yamagata regional growth investment fund, Kirayaka Capital Co., Ltd., and Shinsei Bank. It does not give any details on the number or percentage of shares sold or if they diluted to sell these shares, though.
True, I just like to run with analogies that have been made. What I am suprised hasn’t been pointed out in this case is that the tortoise has had a huge head start which looks like it may come down to the wire at the end, even with the hare giving their all.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM